FDA approves NCE Gepirone (EXXUA) for Ma
Fabre-Kramer Pharmaceuticals Inc. (Fabre-Kramer), a biopharmaceutical company announced approval of Exxuaâ„¢ (gepirone hydrochloride extended-release tablets)
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations